KRAS and non-small cell lung carcinoma: In contrast to the knock-down experiments, CRISPR-driven UHRF1 knock-out also significantly impaired 2D proliferation and colony formation of human NSCLC cell lines carrying oncogenic KRAS (Supplementary Fig. 2b–d).